Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD
Clinical trial NCT03203642 · COMPLETED
Trial details
- NCT number
- NCT03203642
- Sponsor
- Kadmon, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-12
- Primary completion
- 2022-01-25
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.